Key facts
- Notable investors include Qingdao Yangguang Capital, Nanchuang Research Institute.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Jun Future
- ·The full record, as it builds
Funding rounds
No funding rounds for Jun Future are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jun Future
Manufacturer of biopharmaceutical products intended to advance human health through innovative therapies. The company offers proprietary drug development platforms and specialized research capabilities, enabling healthcare providers to offer improved treatment options and enhanced patient outcomes.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2021
- Website
- junfuture.com/
- Ownership
- Privately Held (backing)
Jun Future doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jun Future shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jun Future in its N-PORT filings yet. We sweep new filings monthly.